Long-acting injectable cabotegravir (CAB LA) for HIV prevention: WHO guidelines, implementation considerations, and project examples

26 October 2022 10:00 – 11:30 CET

Overview

During this 90-minutes webinar of the WHO Global PrEP Network, our speakers provided an overview of the new WHO guidelines on CAB-LA, discussed implementation issues specifically relating to HIV testing and drug resistance, and highlighted examples of planned implementation project in sub-Saharan Africa and Asia.

Speakers

  • Michelle Rodolph (WHO, Switzerland)
  • Cheryl Johnson (WHO, Switzerland)
  • Anita Sands (WHO, Switzerland)
  • Seth Inzaule (WHO consultant, Switzerland)
  • Amrit Kaur Ahluwalia (Tufts University, USA)
  • Elizabeth Irungu (Jhpiego, Kenya)
  • Catherine Martin (Wits RHI, South Africa)
  • Kimberly Green (PATH, Viet Nam)

Chair: Dr Heather-Marie Schmidt, UNAIDS Regional Office for Asia and the Pacific, Thailand

Related

Webinar recording

More

Global HIV Programme